December 19, 2012 08:16 AM Eastern Daylight Time

BUSINESS WIRE

CORRECTING and REPLACING First U.S. Patient Treated Following FDA Approval of Cook Medical’s First-of-Its-Kind Zilver® PTX® Drug-Eluting Peripheral Stent

Cook Medical's Zilver(R) PTX(R) Drug-Eluting Peripheral Stent (Photo: Business Wire)

Cook Medical's Zilver(R) PTX(R) Drug-Eluting Peripheral Stent (Photo: Business Wire)

Opens in new window

Download

Full Size JPEG, 3000x1083, 1.0 MB
Small JPEG, 480x173, 47.0 KB
Preview JPEG, 144x52, 5.5 KB
Thumbnail JPEG, 72x26, 1.9 KB

Smart Multimedia Gallery

Cook Medical's Zilver(R) PTX(R) Drug-Eluting Peripheral Stent (Photo: Business Wire)

Cook Medical's Zilver(R) PTX(R) Drug-Eluting Peripheral Stent (Photo: Business Wire)

http://www.businesswire.com/multimedia/home/20121218006434/en/2810395/CORRECTING-REPLACING-U.S.-Patient-Treated-FDA-Approval

View and Share Logo

Share

Email

All News | News with Multimedia > Press Release: CORRECTING and REPLACING First U.S. Patient Tre...